S 4303 · 117th Congress
Interchangeable Biologics Clarity Act
<p><b>Interchangeable Biologics Clarity Act</b></p> <p>This bill provides a statutory definition for<i> first interchangeable biosimilar biological product</i> and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.</p>
- Sponsor
- Kaine, Tim (D-VA)
- Introduced
- 2022-05-25
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
Digging through Congress... 🔍